Stay informed about our latest innovations

LentiFlash™ particles carrying CRISPR-Cas9 technology show promising results to disrupt targeted genes in several therapeutic fields!

Try pre-made lentiviral particles carrying reporter genes driven by tissue-specific promoters for both in vitro and in vivo applications.

RNA delivery into primary T cells for both gene editing & immunotherapy applications.